| |
| |
| Accelerate Your Orphan Drug
to Clinic and Beyond |
|
|
| The pressure to get orphan drug development right on the first try is an enormous undertaking, consuming time, cost and resources. With over 85 years of experience developing world-class formulations, Catalent has extensive expertise in advancing hundreds of orphan projects from small molecule to biologics and cell and gene therapy. |
|
|
| From formulation development to patient-focused dose design to flexible supply, partnering with Catalent reduces risk, accelerates scale-up and helps transform science and innovation into better real-world patient treatments. |
|
|
| |
| Catalent's Newly Expanded Oral and
High Potent Capabilities at the State-of-the-Art Greenville, N.C. Facility |
|
|
| Catalent's recent acquisition of Metrics Contract Services, has strengthened Catalent's capabilities in integrated oral solid formulation development, manufacturing, and packaging to help customers simplify and accelerate their programs, while also expanding capacity to handle highly potent compounds.
|
|
|
| The Greenville, N.C. facility seamlessly integrates into Catalent's industry-leading oral development and manufacturing network, adding fit-for-scale capacity and expertise to meet the demand for potent handling capabilities and small to mid-size batch needs. |
|
|
| |
| Article: Concept to Dosing
Challenges in New Orphan Drugs |
|
|
| As drug developers look to address unmet medical needs for orphan diseases, working with experienced partners can help in navigating key challenges such as managing limited API supply and needing flexibility in manufacturing scale to accommodate small patient populations. Read this article that shares insights from industry experts on key strategies for managing the complexities of orphan drug development. |
|
|
| |
| Executive Summary: Strategies for
Flexible Manufacturing |
|
|
| The changing landscape of drug development continues to be influenced by a rising demand to treat orphan indications and the increasing complexity of compounds, which has led to the need for advanced manufacturing technologies. Download this article for an in-depth look at flexible manufacturing solutions and learn why pharmaceutical and biotech companies are turning to outsourcing partners to help bring their orphan drug to market. |
|
|
| |
| |
| Every brand has a challenge. We have a solution.
|
|
|
| |
| or call +1 877 891 9609 to speak with one of our experts today!
|
|
|
